Tag

biosimilars

As Pfizer’s Drug Patents Expire the Company could Lose Billions

Pfizer’s revenue forecast for 2017 will be $52 billion to $54 billion compared with the $54.3 billion average of analysts’ estimates.  The pharmaceutical company confirmed they would lose billions of dollars ($2.4 billion) in revenue as products lose exclusive sales… Continue Reading →

© 2019 Dawn Ellmore Employment Blog — Powered by WordPress

Theme by Anders NorenUp ↑